Welcome to our Online Press Room

At ZZ Biotech, not only are we known for providing rich content and value information to our audiences, we are also known for providing easy answers for the news media.

Our press room is your one stop spot to:

  • Gain quick company facts
  • Obtain executive leadership bios
  • Read our press releases
  • Access a company spokesperson to assist you in writing a story
  • Learn about current industry news that we have been included in

If you’re a member of the news media and working on deadline where we can assist you, please contact our media relations representative via email. We will respond to all media requests within a 24-hour period. 


Leigh Fazzina
EVC Group

Press Releases

Listed below in chronological order are our news announcements. If you require further assistance with obtaining information contained in one of the announcements, please call our media contact.

ZZ Biotech’s Stroke Drug Moves Closer to Pivotal Phase 3 Clinical Trial as the NIH Awards First Tranche of $30 Million Grant to the Keck School of Medicine of USC

May 24, 2022

ZZ Biotech Announces First Patients Dosed in Phase 2 Clinical Trial of 3K3A-APC for Treatment of Amyotrophic Lateral Sclerosis (ALS)

December 2, 2021

ZZ Biotech Announces FDA Fast Track Designation for Stroke Program

June 12, 2020

ZZ Biotech Announces Preliminary Phase 2 Stroke Trial Results with 3K3A-APC

January 29, 2018

Hope for reversing stroke-induced long-term disability

August 22, 2016

Stem cell therapy heals injured mouse brain

August 22, 2016

ZZ Biotech’s regenerative bio drugs manufactured in Brisbane with support of Biopharmaceuticals Australia

July 6, 2016

ZZ Biotech Acquires Bioatrix

January 12, 2016

$8 Million NIH Grant Will Fund Multicenter Clinical Trial of Stroke Intervention Drug

April 22, 2014

ZZ Biotech Announces Phase 2 Trial with 3K3A-APC in Stroke

April 22, 2014

Experimental stroke therapeutic developed at Keck Medicine of USC also shows promise for people with Lou Gehrig’s disease (ALS)

March 3, 2014

Experimental drug reduces brain damage, eliminates brain hemorrhaging in rodents afflicted by stroke

October 24, 2013

Clinical Trials Start for Stroke Drug Developed by Scripps Research Institute, USC, and ZZ Biotech

August 8, 2012

ZZ Biotech Initiates Phase 1 Study with 3K3A-APC for the Treatment of Acute Ischemic Stroke

August 8, 2012

Experimental Drug May Extend Therapeutic Window for Stroke

July 17, 2012